Cantor Fitzgerald Predicts ORIC FY2026 Earnings
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for ORIC Pharmaceuticals in a note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst P. Agrawal forecasts that the company will earn ($2.15) per share for the year. Cantor Fitzgerald has a “Overweight” rating on […]
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for ORIC Pharmaceuticals in a note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst P. Agrawal forecasts that the company will earn ($2.15) per share for the year. Cantor Fitzgerald has a “Overweight” rating on […]
